Quantitation of glioma-reactive cytolytic T lymphocyte precursors by means of limiting dilution analysis - PubMed (original) (raw)

Quantitation of glioma-reactive cytolytic T lymphocyte precursors by means of limiting dilution analysis

J J Tzeng et al. J Immunol Methods. 1992.

Abstract

The purpose of the present study was to define the usefulness of limiting dilution analysis (LDA) to enumerate glioma-reactive cytolytic T lymphocytes (CTL) as a constituent of tumor infiltrating lymphocytes (TIL) isolated from rat gliomas. Optimum LDA microculture conditions were defined by co-cultivating graded numbers of responder TIL together with 10(5) irradiated syngeneic rat splenocytes, 10(3) irradiated glioma cells, and 10 U/well of recombinant interleukin-2 incubated for 8 days. Antigenic specificity of the anti-tumor response was demonstrated by high levels of [3H]thymidine incorporation by TIL derived from F98 gliomas following stimulation with irradiated F98 glioma cells compared to low levels following stimulation with the antigenically distinct D74 glioma cells. Limiting dilution analysis showed that cytolytic T lymphocyte-precursors were present in TIL of F98 gliomas of immunized rats at an approximate frequency of 300 CTL/10(6) TIL, indicating that less than 1% of the TIL were tumor-reactive CTL. As determined by cell depletion experiments using various MoAbs and complement, the majority of the cytolytic activity detected against glioma targets was mediated by OX-8+ TIL. Split culture experiments revealed that high levels of glioma-reactive CTL activity and low levels of NK activity, which are simultaneously detected among TIL, were mediated by separate cell populations. Our data demonstrate that LDA microcultures can be used as a powerful tool to differentiate tumor-reactive CTL from other effector cell populations.

PubMed Disclaimer

Cited by

Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.
Sahu U, Barth RF, Otani Y, McCormack R, Kaur B. Sahu U, et al. J Neuropathol Exp Neurol. 2022 Apr 27;81(5):312-329. doi: 10.1093/jnen/nlac021. J Neuropathol Exp Neurol. 2022. PMID: 35446393 Free PMC article. Review.
Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
Ciesielski MJ, Kazim AL, Barth RF, Fenstermaker RA. Ciesielski MJ, et al. Cancer Immunol Immunother. 2005 Feb;54(2):107-19. doi: 10.1007/s00262-004-0576-y. Epub 2004 Aug 31. Cancer Immunol Immunother. 2005. PMID: 15340764 Free PMC article.
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.
Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE. Nabel GJ, et al. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11307-11. doi: 10.1073/pnas.90.23.11307. Proc Natl Acad Sci U S A. 1993. PMID: 8248244 Free PMC article. Clinical Trial.
Induction of apoptosis in glioma cells by molecules released from activated macrophages.
Chen GG, Chu YS, Chak EC, Leung BC, Poon WS. Chen GG, et al. J Neurooncol. 2002 May;57(3):179-86. doi: 10.1023/a:1015763916020. J Neurooncol. 2002. PMID: 12125980

Quantitation of glioma-reactive cytolytic T lymphocyte precursors by means of limiting dilution analysis - PubMed (original) (raw)